<DOC>
	<DOCNO>NCT01017107</DOCNO>
	<brief_summary>Activated protein C ( APC ) show reduce mortality severe sepsis ( Bernard et al . 2001b ) . The clinical picture severe acute pancreatitis ( AP ) similar sepsis . The investigator conduct randomised double-blinded placebo-controlled pilot study AP patient ( 16+16 ) dose APC proven efficacious safe septic patient . The aim study investigate whether APC replacement therapy diminishes occurrence severity organ dysfunction patient severe AP . The effect APC inflammatory hemostatic parameter also assess .</brief_summary>
	<brief_title>Activated Protein C Severe Acute Pancreatitis</brief_title>
	<detailed_description>The study start 2003 finished 2007 . The study register The Helsinki University Central Hospital study register 2003 .</detailed_description>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Protein C</mesh_term>
	<criteria>Admitted hospital within 72 h onset pain . Plasma amylase concentration three time upper limit normal range and/or CT finding compatible AP . Organ failure &lt; 48h onset first organ failure HIV / B C hepatitis infection Pregnancy breast feed Active bleeding Increased risk bleeding ( thrombocytes &lt; 30x10E9/L INR &gt; 3.0 Gastrointestinal bleeding within 6 week intracranial stroke within 3 month study Intravenous contrast extravasation sign ( fresh hematoma ) suggest active hemorrhage within pancreas peripancreatic area admission CT scan Use antithrombin III within 12 h Use acetylsalicylic acid glycoprotein IIB/IA antagonist within 7 day / Thrombolytic therapy within 3 day Surgery require general spinal anaesthesia within 12 h Previous pancreatic surgery Application epidural catheter within 48 h</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>acute pancreatitis</keyword>
	<keyword>treatment</keyword>
	<keyword>organ failure</keyword>
	<keyword>activate protein c</keyword>
</DOC>